253 related articles for article (PubMed ID: 21701587)
21. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
Chang PY; Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
[TBL] [Abstract][Full Text] [Related]
22. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.
Wang Z; Xie J; Yan M; Wang J; Wang X; Zhang J; Zhang Y; Li P; Lei X; Huang Q; Lin S; Guo X; Liu Q
Oncotarget; 2016 May; 7(18):26765-79. PubMed ID: 27049918
[TBL] [Abstract][Full Text] [Related]
24. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
Liao C; Li M; Chen X; Tang C; Quan J; Bode AM; Cao Y; Luo X
J Exp Clin Cancer Res; 2023 Oct; 42(1):261. PubMed ID: 37803433
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.
Chen J; Hu CF; Hou JH; Shao Q; Yan LX; Zhu XF; Zeng YX; Shao JY
J Transl Med; 2010 Mar; 8():30. PubMed ID: 20338061
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
[TBL] [Abstract][Full Text] [Related]
27. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
[TBL] [Abstract][Full Text] [Related]
28. Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.
Siegler G; Meyer B; Dawson C; Brachtel E; Lennerz J; Koch C; Kremmer E; Niedobitek E; Gonnella R; Pilch BZ; Young LS; Niedobitek G
Int J Cancer; 2004 Nov; 112(2):265-72. PubMed ID: 15352039
[TBL] [Abstract][Full Text] [Related]
29. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
[TBL] [Abstract][Full Text] [Related]
30. LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.
Sun J; Hu C; Zhu Y; Sun R; Fang Y; Fan Y; Xu F
PLoS One; 2015; 10(8):e0134896. PubMed ID: 26244812
[TBL] [Abstract][Full Text] [Related]
31. Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.
Chew MM; Gan SY; Khoo AS; Tan EL
BMC Cancer; 2010 Oct; 10():574. PubMed ID: 20964870
[TBL] [Abstract][Full Text] [Related]
32. Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma.
Li B; Huang G; Zhang X; Li R; Wang J; Dong Z; He Z
BMC Cancer; 2013 Mar; 13():124. PubMed ID: 23496845
[TBL] [Abstract][Full Text] [Related]
33. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
34. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
Dawson CW; Eliopoulos AG; Blake SM; Barker R; Young LS
Virology; 2000 Jun; 272(1):204-17. PubMed ID: 10873763
[TBL] [Abstract][Full Text] [Related]
35. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
[TBL] [Abstract][Full Text] [Related]
36. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.
Mei YP; Zhou JM; Wang Y; Huang H; Deng R; Feng GK; Zeng YX; Zhu XF
Cell Cycle; 2007 Jun; 6(11):1379-85. PubMed ID: 17507800
[TBL] [Abstract][Full Text] [Related]
37. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
[TBL] [Abstract][Full Text] [Related]
38. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
[TBL] [Abstract][Full Text] [Related]
39. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
